Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients

Abstract

An imbalance between T Helper 1 (T_H1) and T Helper 2 (T_H2) cytokine production is important for the pathogenesis of systemic lupus erythematosus (SLE). We aimed to investigate gene—gene associations of T_H1 and T_H2 cytokines genes in Chinese patients with SLE. Twenty single nucleotide polymorphisms (SNPs) in eight cytokines genes were genotyped in 110 SLE patients and 138 healthy controls in a case—control association study. The minor allelic frequencies of interleukin4(IL4) -590 T/C, -33 T/C, 9241C/G, and IL10 -592 A/C were significantly increased in SLE patients compared with those in controls (p < 0.05). None of the separate 20 SNPs showed significant association with SLE after Bonferroni correction. An IL4 haplotype -590C/-33C/9241G/14965C was significantly associated with SLE (odds ratio 3.7, 95% confidence interval [CI] 1.5—8.9, p = 0.004, Bonferroni-corrected p = 0.024). A borderline significant three-locus gene—gene interaction among IL4 9241 C/G, IL4 -33 T/C, signal transducer and activator of transcription 6, IL4-induced (STAT6) 2892 C/T was detected by a multifactor dimensionality reduction test (p = 0.051). However, the presence of two at-risk genotypes lead to increased risk of SLE for two-locus interaction using logistic regression method. The risk of SLE increased significantly when a subject has two at-risk genotypes for IL4 -590C and STAT6 2892C (odds ratio, 3.24, 95% CI 1.5—7.0, p = 0.003, Bonferroni-corrected p = 0.009), IL4 -33C and STAT6 2892C (odds ratio 3.06, 95% CI 1.4— 6.7, p = 0.005, Bonferroni-corrected p = 0.015), as well as IL4 9241G and STAT6 2892C (odds ratio 3.34, 95% CI 1.6—7.1, p = 0.002, Bonferroni-corrected p = 0.006). Further, plasma IL-4 concentrations were significantly lower in SLE patients than in healthy controls (1.59 + 3.53 versus 5.67 + 11.28 pg/ml, p = 0.042). These results indicated that IL4 and STAT6 genes might be involved in the etiology of SLE and potentially increased SLE risk through their interaction effect in Chinese patients.

Keywords

cytokine gene polymorphism IL4 IL18 STAT6 systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Rahman A. , Isenberg DA Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939.

Mosmann TR , Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-146.

Balomenos D. , Rumold R. , Theofilopoulos AN Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRLlpr mice. J Clin Invest 1998; 101: 364-371.

Peng SL , Moslehi J. , Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997; 99: 1936-1946.

Santiago ML , Fossati L. , Jacquet C. , Muller W. , Izui S. , Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997; 185: 65-70.

Schorlemmer HU , Dickneite G. , Kanzy EJ , Enssle KH. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R) . Inflamm Res 1995; 44(Suppl 2): S194-S196.

Ishida H. , Muchamuel T. , Sakaguchi S. , Andrade S. , Menon S. , Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994 ; 179: 305-310.

Lit LC , Wong CK , Li EK , Tam LS , Lam CW , Lo YM Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007; 34: 89-96.

Sugimoto K. , Morimoto S. , Kaneko H. , et al. Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression. Autoimmunity 2002; 35: 381-387.

10.

Tokano Y. , Morimoto S. , Kaneko H. , et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999; 116: 169-173.

11.

Goldman M. , Druet P. , Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12: 223-227.

12.

Funauchi M. , Ikoma S. , Enomoto H. , Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 219-224.

13.

Csiszar A. , Nagy G. , Gergely P. , Pozsonyi T. , Pocsik E. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 2000 ; 122: 464-470.

14.

Gomez D. , Correa PA , Gomez LM , Cadena J. , Molina JF , Anaya JM

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

Semin Arthritis Rheum 2004; 33: 404-413.

15.

Viallard JF , Pellegrin JL , Ranchin V. , et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999; 115: 189-195.

16.

Wong CK , Ho CY , Li EK , Lam CW Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589-593.

17.

Calvani N. , Tucci M. , Richards HB , Tartaglia P. , Silvestris F. Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 2005; 4: 542-548.

18.

Wu MC , Huang CM , Tsai JJ , Chen HY , Tsai FJ Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003; 12: 21-25.

19.

Kanemitsu S. , Takabayashi A. , Sasaki Y. , et al. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 1298-1300.

20.

Schotte H. , Schluter B. , Rust S. , Assmann G. , Domschke W. , Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology ( Oxford) 2001; 40: 393-400.

21.

Lee YH , Harley JB , Nath SK Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility . Eur J Hum Genet 2006; 14: 364-371.

22.

Parks CG , Cooper GS , Dooley MA , et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States . Ann Rheum Dis 2004; 63: 91-94.

23.

Chong WP , Ip WK , Wong WH , Lau CS , Chan TM , Lau YL Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus . Genes Immun 2004; 5: 484-492.

24.

Sanchez E. , Palomino-Morales RJ , Ortego-Centeno N. , et al. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 2009; 18: 3739-3748.

25.

Lin YJ , Wan L. , Lee CC , et al. Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun 2007; 8: 302-307.

26.

Lin YJ , Wan L. , Sheu JJ , et al. A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients. Lupus 2008; 17: 124-127.

27.

Moore JH The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003; 56: 73-82.

28.

Hulkkonen J. , Pertovaara M. , Antonen J. , Lahdenpohja N. , Pasternack A. , Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren’s syndrome. Arthritis Rheum 2001; 44: 176-179.

29.

Seegers D. , Zwiers A. , Strober W. , Pena AS , Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419-423.

30.

Giedraitis V. , He B. , Huang WX , Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation . J Neuroimmunol 2001; 112: 146-152.

31.

Vercelli D. Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol 2002; 2: 389-393.

32.

Rosenwasser LJ , Klemm DJ , Dresback JK , et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25(Suppl 2): 74-78; discussion 95-76.

33.

Schedel M. , Carr D. , Klopp N. , et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol 2004; 114: 1100-1105.

34.

Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

35.

Yang HC , Lin CH , Hsu CL , et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci 2006; 13: 489-498.

36.

Wang IJ , Chiang TH , Shih YF , et al. The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Mol Vis 2006; 12: 1223-1232.

37.

Klipper-Aurbach Y. , Wasserman M. , Braunspiegel-Weintrob N. , et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995; 45: 486-490.

38.

Tregouet DA , Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007; 23: 1038-1039.

39.

Hahn LW , Ritchie MD , Moore JH Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376-382.

40.

Motsinger AA , Brassat D. , Caillier SJ , et al. Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics 2007; 8: 11-20.

41.

Schedel M. , Frei R. , Bieli C. , et al. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression. J Allergy Clin Immunol 2009; 124: 583-589.

42.

Kabesch M. , Schedel M. , Carr D. , et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006; 117: 269-274.

43.

Nelms K. , Keegan AD , Zamorano J. , Ryan JJ , Paul WE The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738.

44.

Erb KJ , Ruger B. , von Brevern M. , Ryffel B. , Schimpl A. , Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 1997; 185: 329-339.

45.

Singh RR , Saxena V. , Zang S. , et al. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003; 170: 4818-4825.

46.

Nagy G. , Pallinger E. , Antal-Szalmas P. , et al. Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus . Immunol Lett 2000; 74: 207-210.

47.

Xu Q. , Tin SK , Sivalingam SP , Thumboo J. , Koh DR , Fong KY Interleukin-18 promoter gene polymorphisms in Chinese patients with systemic lupus erythematosus: association with CC genotype at position -607. Ann Acad Med Singapore 2007; 36: 91-95.

48.

Chen DY , Hsieh CW , Chen KS , Chen YM , Lin FJ , Lan JL Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 2009; 18: 29-37.